|
Looking for a Bottom Shares of Apple are down 9.4% in September
and 20% in 2022, putting Apple on pace for its worst year since 2008, when it
lost 57%. It's a sharp contrast to the last three years, in which Apple stock
gained 34%, 81%, and 86%, respectively. Apple's recent slide has added a new dynamic
to tech's terrible year. Until now, Apple had been something of a safe haven.
The stock has been down in 2022, but not as much as its big tech peers. Now sentiment may be changing. BofA
Securities cut its rating on Apple to Neutral from Buy. The firm said that
Wall Street's earnings estimates are still too high given a slowdown in
consumer spending. Apple, after all, is more of a direct play
on the consumer than the rest of Big Tech. Microsoft
and Amazon.com have their enterprise cloud business, and
Alphabet and Meta Platforms sell
advertising to businesses, not consumers. That puts Apple in a tough spot. "What we’re seeing is the consumer
spending is starting to slowdown," BofA analyst Wamsi
Mohan told CNBC about the downgrade. "Apple has been
resilient to estimate revisions, despite the world changing. We think there's
significant risk to these numbers." Most of Wall Street remains bullish on
Apple, it's worth noting. Of the 41 analysts that cover the stock, 32 have a
Buy (or Overweight) rating, according to FactSet. There are six Holds, and
just three Sells. If you're an Apple shareholder, you could view that as
bullish or bearish. Either there's wisdom in the crowd or Apple shares have
further to fall as Wall Street begins to reassess. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, October 4, 2022
Looking for a Bottom
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment